Alnylam Pharmaceuticals Stock Target Price and Analyst Consensus
| ALNY Stock | USD 145.16 0.16 0.11% |
The current analyst and expert consensus on Alnylam Pharmaceuticals is Strong Buy with 10 buy recommendations. The current projected Alnylam Pharmaceuticals target price consensus is 229.39, with 30 analyst opinions. The most common way Alnylam Pharmaceuticals analysts use to provide public buy-or-sell recommendation is financial statements analysis. They also talk to Alnylam Pharmaceuticals executives, vendors, and/or customers. Alnylam Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Alnylam Pharmaceuticals target price to derive its highest and lowest estimates based on target price estimated volatility of 0.0. Check out Macroaxis Advice on Alnylam Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Alnylam Stock please use our How to Invest in Alnylam Pharmaceuticals guide.
Lowest Forecast 208.74 | Highest Forecast 254.62 | Target Price 229.39 |
Alnylam |
It's important to approach Alnylam Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Alnylam Pharmaceuticals price targets
Alnylam Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Alnylam Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Alnylam Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Alnylam Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Alnylam Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Alnylam Pharmaceuticals is a key component of Alnylam Pharmaceuticals valuation and have some predictive power on the future returns of a Alnylam Pharmaceuticals.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alnylam Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested over 70 shares | |
 | Chemicals Invested over 40 shares | |
 | Momentum Invested over 200 shares | |
 | Banking Invested over 30 shares | |
 | Social Domain Invested few shares | |
 | Investor Favorites Invested over 200 shares | |
 | Business Services Invested few shares | |
Check out Macroaxis Advice on Alnylam Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Alnylam Stock please use our How to Invest in Alnylam Pharmaceuticals guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Alnylam Stock analysis
When running Alnylam Pharmaceuticals' price analysis, check to measure Alnylam Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alnylam Pharmaceuticals is operating at the current time. Most of Alnylam Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alnylam Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alnylam Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alnylam Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
The data published in Alnylam Pharmaceuticals' official financial statements usually reflect Alnylam Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Alnylam Pharmaceuticals. For example, before you start analyzing numbers published by Alnylam accountants, it's critical to develop an understanding of what Alnylam Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Alnylam Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Alnylam Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Alnylam Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Alnylam Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Alnylam Pharmaceuticals' management manipulating its earnings.